Dianthus Therapeutics, Inc. /DE/ Stock-Based Compensation
Dianthus Therapeutics, Inc. /DE/ (DNTH) reported Stock-Based Compensation of $22.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-04
- Dianthus Therapeutics, Inc. /DE/ share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $11.90M, a 108.52% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $10.60M, a 99.47% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $5.98M, a 52.58% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $5.79M, a 50.89% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ share-based payment arrangement, noncash expense for fiscal 2025 was $22.79M, a 76.77% increase from fiscal 2024.
- Dianthus Therapeutics, Inc. /DE/ share-based payment arrangement, noncash expense for fiscal 2024 was $12.89M, a 344.62% increase from fiscal 2023.
- Dianthus Therapeutics, Inc. /DE/ share-based payment arrangement, noncash expense for fiscal 2023 was $2.90M, a 91.04% increase from fiscal 2022.
- Dianthus Therapeutics, Inc. /DE/ share-based payment arrangement, noncash expense for fiscal 2022 was $1.52M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $22.50M 10-Q · filed 2026-08-04 | $28.48M derived: sum of 3 quarters · filed 2026-08-04 | $34.27M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $10.60M 10-Q · filed 2026-05-05 | $16.58M derived: sum of 2 quarters · filed 2026-05-05 | $22.37M derived: sum of 3 quarters · filed 2026-05-05 | $28.08M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $5.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $11.77M derived: sum of 2 quarters · filed 2026-03-09 | $17.48M derived: sum of 3 quarters · filed 2026-08-04 | $22.79M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $5.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $11.50M derived: sum of 2 quarters · filed 2026-08-04 | $16.82M 10-Q · filed 2025-11-05 | $20.73M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $5.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $11.02M 10-Q · filed 2026-08-04 | $14.94M derived: sum of 3 quarters · filed 2026-08-04 | $18.78M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $5.32M 10-Q · filed 2026-05-05 | $9.23M derived: sum of 2 quarters · filed 2026-05-05 | $13.07M derived: sum of 3 quarters · filed 2026-05-05 | $16.17M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $7.76M derived: sum of 2 quarters · filed 2026-03-09 | $10.86M derived: sum of 3 quarters · filed 2026-03-09 | $12.89M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $3.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.94M derived: sum of 2 quarters · filed 2025-11-05 | $8.98M 10-Q · filed 2025-11-05 | $9.70M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $5.14M 10-Q · filed 2025-08-07 | $5.86M derived: sum of 3 quarters · filed 2025-08-07 | $7.04M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $2.04M 10-Q · filed 2025-05-12 | $2.76M derived: sum of 2 quarters · filed 2025-05-12 | $3.94M derived: sum of 3 quarters · filed 2025-05-12 | $4.40M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $726.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.91M derived: sum of 2 quarters · filed 2025-03-11 | $2.37M derived: sum of 3 quarters · filed 2025-03-11 | $2.90M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.64M derived: sum of 2 quarters · filed 2024-11-07 | $2.17M 10-Q · filed 2024-11-07 | $2.69M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $462.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $995.00K 10-Q · filed 2024-08-08 | $922.00K 10-Q · filed 2023-08-03 | $1.51M derived: sum of 3 quarters · filed 2024-08-08 | -$1.24M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $533.00K 10-Q · filed 2024-05-09 | $506.00K 10-Q · filed 2023-05-15 | $1.05M derived: sum of 2 quarters · filed 2024-05-09 | -$1.70M derived: sum of 3 quarters · filed 2024-05-09 | $146.00K derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $513.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$2.23M derived: sum of 2 quarters · filed 2024-03-21 | -$387.00K derived: sum of 3 quarters · filed 2024-03-21 | $1.52M 10-K · filed 2024-03-21 | $7.02M 10-K · filed 2023-03-23 | |||
| 2022-09-30 | -$2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$900.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.00M 10-Q · filed 2023-11-09 | $5.26M 10-Q · filed 2022-11-03 | -$7.06M derived: sum of 4 quarters · filed 2023-12-21 | |||
| 2022-06-30 | $1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.75M 10-Q · filed 2023-08-03 | -$4.31M derived: sum of 3 quarters · filed 2023-12-21 | -$513.00K derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2022-03-31 | $1.91M 10-Q · filed 2023-05-15 | -$6.16M derived: sum of 2 quarters · filed 2023-12-21 | -$2.36M derived: sum of 3 quarters · filed 2023-12-21 | -$224.00K derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2021-12-31 | -$8.06M derived: 8-K 12 month − 10-Q 9 month · filed 2023-12-21 | -$4.26M derived: sum of 2 quarters · filed 2023-12-21 | -$2.13M derived: sum of 3 quarters · filed 2023-12-21 | $63.00K 8-K · filed 2023-12-21 | $10.31M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $5.93M derived: sum of 2 quarters · filed 2022-11-03 | $8.13M 10-Q · filed 2022-11-03 | $10.46M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.33M 10-Q · filed 2022-08-04 | $6.66M derived: sum of 3 quarters · filed 2022-08-04 | $9.02M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $2.19M 10-Q · filed 2022-05-16 | $4.52M derived: sum of 2 quarters · filed 2022-05-16 | $6.89M derived: sum of 3 quarters · filed 2022-05-16 | $9.39M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $4.70M derived: sum of 2 quarters · filed 2022-03-08 | $7.20M derived: sum of 3 quarters · filed 2022-03-08 | $9.94M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | $2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $4.87M derived: sum of 2 quarters · filed 2021-11-04 | $7.61M 10-Q · filed 2021-11-04 | $9.67M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $5.24M 10-Q · filed 2021-08-05 | $7.31M derived: sum of 3 quarters · filed 2021-08-05 | $10.07M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $2.74M 10-Q · filed 2021-05-06 | $4.80M derived: sum of 2 quarters · filed 2021-05-06 | $7.56M derived: sum of 3 quarters · filed 2021-05-06 | $10.16M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $4.82M derived: sum of 2 quarters · filed 2021-03-03 | $7.42M derived: sum of 3 quarters · filed 2021-03-03 | $10.00M 10-K · filed 2021-03-03 | ||||
| 2019-09-30 | $2.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $5.36M derived: sum of 2 quarters · filed 2020-11-05 | $7.94M 10-Q · filed 2020-11-05 | $10.49M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $5.18M 10-Q · filed 2020-08-06 | $7.73M derived: sum of 3 quarters · filed 2020-08-06 | $11.40M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $2.58M 10-Q · filed 2020-05-07 | $5.13M derived: sum of 2 quarters · filed 2020-05-07 | $8.80M derived: sum of 3 quarters · filed 2020-05-07 | $11.86M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $6.23M derived: sum of 2 quarters · filed 2020-03-03 | $9.28M derived: sum of 3 quarters · filed 2020-03-03 | $10.70M 10-K · filed 2020-03-03 | ||||
| 2018-09-30 | $3.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $6.73M derived: sum of 2 quarters · filed 2019-11-13 | $8.15M 10-Q · filed 2019-11-13 | $8.93M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-06-30 | $3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $4.48M 10-Q · filed 2019-08-08 | $5.25M derived: sum of 3 quarters · filed 2020-03-03 | $5.81M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-03-31 | $1.43M 10-Q · filed 2019-05-09 | $2.20M derived: sum of 2 quarters · filed 2020-03-03 | $2.76M derived: sum of 3 quarters · filed 2020-03-03 | |||||
| 2017-12-31 | $773.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $1.34M derived: sum of 2 quarters · filed 2020-03-03 | $2.26M 10-K · filed 2020-03-03 | |||||
| 2017-09-30 | $565.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.49M 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | $921.00K 10-Q · filed 2018-08-09 | |||||||
| 2016-12-31 | $662.00K 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |